122 related articles for article (PubMed ID: 1442146)
1. In vivo and in vitro release of indomethacin from water-soluble and fatty base suppositories.
Furuno K; Gomita Y; Yoshida T; Oishi R; Saeki K; Araki Y
Acta Med Okayama; 1992 Aug; 46(4):223-31. PubMed ID: 1442146
[TBL] [Abstract][Full Text] [Related]
2. Influence of storage temperature on indomethacin release from fatty-base suppositories in vitro and in vivo.
Yoshida T; Itoh Y; Gomita Y; Oishi R
Acta Med Okayama; 1991 Feb; 45(1):37-42. PubMed ID: 2063694
[TBL] [Abstract][Full Text] [Related]
3. In vitro methods for the evaluation of drug availability from suppositories: comparison between biological and artificial membranes.
Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
Pharmazie; 2005 Oct; 60(10):756-60. PubMed ID: 16259123
[TBL] [Abstract][Full Text] [Related]
4. Investigation on rectal absorption of indomethacin from sustained-release hydrogel suppositories prepared with water-soluble dietary fibers, xanthan gum and locust bean gum.
Watanabe K; Yakou S; Takayama K; Machida Y; Isowa K; Nagai T
Biol Pharm Bull; 1993 Apr; 16(4):391-4. PubMed ID: 8395281
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
6. Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs.
Aoyagi N; Kaniwa N; Takeda Y; Uchiyama M; Takamura F; Kido Y
Chem Pharm Bull (Tokyo); 1988 Dec; 36(12):4933-40. PubMed ID: 3246053
[No Abstract] [Full Text] [Related]
7. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
Kim JY; Ku YS
Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
[TBL] [Abstract][Full Text] [Related]
8. The in Vitro Release of Indomethacin from Suppositories: Effects of Bases and Comparison of Different Dissolution Methods.
Mori K; Hori S; Kawata T; Kogure S; Matsumoto K; Hasegawa T; Akimoto M
Chem Pharm Bull (Tokyo); 2017; 65(7):674-677. PubMed ID: 28674341
[TBL] [Abstract][Full Text] [Related]
9. Medicament release from suppository bases I: Physicochemical characteristics and bioavailability of indomethacin in rabbits.
Vidras NJ; Reid VE; Bohidar NR; Plakogiannis FM
J Pharm Sci; 1982 Aug; 71(8):945-9. PubMed ID: 7120104
[TBL] [Abstract][Full Text] [Related]
10. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
Realdon N; Ragazzi E; Ragazzi E
Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
[TBL] [Abstract][Full Text] [Related]
11. Absorption and distribution of radioactivity from suppositories containing 3H-benzocaine in rats.
Ayres JW; Lorskulsint D; Lock A; Kuhl L; Laskar PA
J Pharm Sci; 1976 Jun; 65(6):832-8. PubMed ID: 932967
[TBL] [Abstract][Full Text] [Related]
12. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
Takatori T; Shimono N; Higaki K; Kimura T
Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
[TBL] [Abstract][Full Text] [Related]
14. Effect of the surfactant on the availability of piroxicam as a poorly hydrosoluble drug from suppositories.
Dal Zorro M; Franceschinis E; Punchina A; Realdon N
Pharmazie; 2012 Jan; 67(1):37-45. PubMed ID: 22393829
[TBL] [Abstract][Full Text] [Related]
15. In vitro release of tegafur from a fatty-base suppository and in vivo bioavailability of tegafur.
Fukuda T; Yoshida T; Eto K; Gomita Y; Araki Y
Acta Med Okayama; 1986 Aug; 40(4):195-200. PubMed ID: 3094322
[TBL] [Abstract][Full Text] [Related]
16. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
17. Preparation and characterization of intravaginal vardenafil suppositories targeting a complementary treatment to boost in vitro fertilization process.
Gomaa E; Abu Lila AS; Hasan AA; Ghazy FS
Eur J Pharm Sci; 2018 Jan; 111():113-120. PubMed ID: 28964952
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and release studies of indomethacin suppositories.
Sah ML; Saini TR
Indian J Pharm Sci; 2008; 70(4):498-501. PubMed ID: 20046779
[TBL] [Abstract][Full Text] [Related]
20. Modification of the dialysis membrane method for drug release from suppositories.
Yamazaki M; Itoh S; Sasaki N; Tanabe K; Uchiyama M
Pharm Res; 1993 Jun; 10(6):927-9. PubMed ID: 8321864
[No Abstract] [Full Text] [Related]
[Next] [New Search]
